SI2763690T1 - Liksisenatid za uporabo pri zdravljenju stenoze in/ali obstrukcije v sistemu vodov trebušne slinavke - Google Patents
Liksisenatid za uporabo pri zdravljenju stenoze in/ali obstrukcije v sistemu vodov trebušne slinavkeInfo
- Publication number
- SI2763690T1 SI2763690T1 SI201230454T SI201230454T SI2763690T1 SI 2763690 T1 SI2763690 T1 SI 2763690T1 SI 201230454 T SI201230454 T SI 201230454T SI 201230454 T SI201230454 T SI 201230454T SI 2763690 T1 SI2763690 T1 SI 2763690T1
- Authority
- SI
- Slovenia
- Prior art keywords
- lixisenatide
- stenosis
- obstruction
- treatment
- duct system
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/26—Glucagons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Endocrinology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11183867 | 2011-10-04 | ||
| EP12766695.6A EP2763690B1 (en) | 2011-10-04 | 2012-10-02 | Lixisenatide for use in the treatment of stenosis or/and obstruction in the pancreatic duct system |
| PCT/EP2012/069485 WO2013050379A1 (en) | 2011-10-04 | 2012-10-02 | Glp-1 agonist for use in the treatment of stenosis or/and obstruction in the pancreatic duct system |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI2763690T1 true SI2763690T1 (sl) | 2016-03-31 |
Family
ID=46963761
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI201230454T SI2763690T1 (sl) | 2011-10-04 | 2012-10-02 | Liksisenatid za uporabo pri zdravljenju stenoze in/ali obstrukcije v sistemu vodov trebušne slinavke |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20130096060A1 (sl) |
| EP (1) | EP2763690B1 (sl) |
| CY (1) | CY1117394T1 (sl) |
| DK (1) | DK2763690T3 (sl) |
| ES (1) | ES2562651T3 (sl) |
| HR (1) | HRP20160171T1 (sl) |
| HU (1) | HUE028568T2 (sl) |
| PL (1) | PL2763690T3 (sl) |
| PT (1) | PT2763690E (sl) |
| SI (1) | SI2763690T1 (sl) |
| WO (1) | WO2013050379A1 (sl) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RS56632B1 (sr) | 2008-10-17 | 2018-03-30 | Sanofi Aventis Deutschland | Kombinacija insulina i glp-1-agonista |
| AU2010317995B2 (en) | 2009-11-13 | 2014-04-17 | Sanofi-Aventis Deutschland Gmbh | Pharmaceutical composition comprising a GLP-1 agonist, an insulin, and methionine |
| CN102711804B (zh) | 2009-11-13 | 2015-09-16 | 赛诺菲-安万特德国有限公司 | 包含glp-1激动剂和甲硫氨酸的药物组合物 |
| JP6199186B2 (ja) | 2010-08-30 | 2017-09-20 | サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | ２型糖尿病の治療用の医薬の製造のためのａｖｅ００１０の使用 |
| US9821032B2 (en) | 2011-05-13 | 2017-11-21 | Sanofi-Aventis Deutschland Gmbh | Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin |
| JP6367115B2 (ja) | 2011-08-29 | 2018-08-01 | サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | ２型糖尿病患者の血糖コントロールに使用する組合せ医薬 |
| TWI559929B (en) | 2011-09-01 | 2016-12-01 | Sanofi Aventis Deutschland | Pharmaceutical composition for use in the treatment of a neurodegenerative disease |
| TWI780236B (zh) | 2013-02-04 | 2022-10-11 | 法商賽諾菲公司 | 胰島素類似物及/或胰島素衍生物之穩定化醫藥調配物 |
| CN112957455A (zh) | 2014-01-09 | 2021-06-15 | 赛诺菲 | 胰岛素类似物和/或胰岛素衍生物的稳定化药物制剂 |
| MX2016008978A (es) | 2014-01-09 | 2016-10-04 | Sanofi Sa | Formulaciones farmaceuticas de analogos de insulina y/o derivados de insulina estabilizadas y que estan libres de glicerol. |
| CN105899190B (zh) | 2014-01-09 | 2022-06-14 | 赛诺菲 | 门冬胰岛素的稳定化药物制剂 |
| MX2017007699A (es) | 2014-12-12 | 2017-09-18 | Sanofi Aventis Deutschland | Formulacion de proporcion fija de insulina glargina/lixisenatida. |
| TWI748945B (zh) | 2015-03-13 | 2021-12-11 | 德商賽諾菲阿凡提斯德意志有限公司 | 第２型糖尿病病患治療 |
| TW201705975A (zh) | 2015-03-18 | 2017-02-16 | 賽諾菲阿凡提斯德意志有限公司 | 第２型糖尿病病患之治療 |
| WO2022212271A1 (en) * | 2021-03-29 | 2022-10-06 | Sanford Health | Methods and compositions for treating lysosomal storage disorders |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2038597A1 (en) * | 1991-03-19 | 1992-09-20 | Jose P. Garzaran | A method and a pharmaceutical preparation for treating pain |
| US5424286A (en) | 1993-05-24 | 1995-06-13 | Eng; John | Exendin-3 and exendin-4 polypeptides, and pharmaceutical compositions comprising same |
| US5595756A (en) * | 1993-12-22 | 1997-01-21 | Inex Pharmaceuticals Corporation | Liposomal compositions for enhanced retention of bioactive agents |
| ES2319936T5 (es) | 1996-08-08 | 2013-06-24 | Amylin Pharmaceuticals, Inc. | Regulación de la motilidad gastrointestinal |
| PL192359B1 (pl) | 1996-08-30 | 2006-10-31 | Novo Nordisk As | Pochodna GLP-1(7-37) lub analogu GLP-1(7-37), środek farmaceutyczny oraz zastosowanie pochodnej GLP-1(7-37) lub analogu GLP-1(7-37) |
| WO1998030231A1 (en) | 1997-01-07 | 1998-07-16 | Amylin Pharmaceuticals, Inc. | Use of exendins and agonists thereof for the reduction of food intake |
| PT1019077E (pt) | 1997-08-08 | 2008-02-21 | Amylin Pharmaceuticals Inc | Novos compostos agonistas de exendina |
| BR9814189A (pt) | 1997-11-14 | 2000-10-03 | Amylin Pharmaceuticals Inc | "compostos agonistas da exendina" |
| EP1066314B1 (en) | 1997-11-14 | 2007-12-26 | Amylin Pharmaceuticals, Inc. | Novel exendin agonist compounds |
| EP1076066A1 (en) | 1999-07-12 | 2001-02-14 | Zealand Pharmaceuticals A/S | Peptides for lowering blood glucose levels |
| JP5685355B2 (ja) | 2002-07-04 | 2015-03-18 | ジーランド ファーマ アクティーゼルスカブ | Ｇｌｐ−１および糖尿病の処置方法 |
| CA2500295A1 (en) | 2002-10-02 | 2004-04-29 | Zealand Pharma A/S | Stabilized exendin-4 compounds |
| EP1937297A2 (en) | 2005-09-08 | 2008-07-02 | Gastrotech Pharma A/S | Use of a glp-1 molecule for treatment of biliary dyskinesia and/or biliary pain/discomfort |
-
2012
- 2012-10-02 ES ES12766695.6T patent/ES2562651T3/es active Active
- 2012-10-02 PL PL12766695T patent/PL2763690T3/pl unknown
- 2012-10-02 SI SI201230454T patent/SI2763690T1/sl unknown
- 2012-10-02 HU HUE12766695A patent/HUE028568T2/en unknown
- 2012-10-02 US US13/633,563 patent/US20130096060A1/en not_active Abandoned
- 2012-10-02 PT PT127666956T patent/PT2763690E/pt unknown
- 2012-10-02 DK DK12766695.6T patent/DK2763690T3/en active
- 2012-10-02 EP EP12766695.6A patent/EP2763690B1/en not_active Not-in-force
- 2012-10-02 WO PCT/EP2012/069485 patent/WO2013050379A1/en active Application Filing
-
2016
- 2016-02-16 HR HRP20160171TT patent/HRP20160171T1/hr unknown
- 2016-02-24 CY CY20161100151T patent/CY1117394T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HUE028568T2 (en) | 2016-12-28 |
| EP2763690A1 (en) | 2014-08-13 |
| WO2013050379A1 (en) | 2013-04-11 |
| PL2763690T3 (pl) | 2016-04-29 |
| ES2562651T3 (es) | 2016-03-07 |
| DK2763690T3 (en) | 2016-02-15 |
| HRP20160171T1 (hr) | 2016-03-11 |
| PT2763690E (pt) | 2016-03-23 |
| US20130096060A1 (en) | 2013-04-18 |
| CY1117394T1 (el) | 2017-04-26 |
| EP2763690B1 (en) | 2015-11-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SI2763690T1 (sl) | Liksisenatid za uporabo pri zdravljenju stenoze in/ali obstrukcije v sistemu vodov trebušne slinavke | |
| GB2485291B (en) | Cannabidiol for use in the treatment of generalised and/or partial seizures | |
| HK1175170A1 (en) | Pyridine and pyrazine derivative for the treatment of cf cf | |
| EP2613735A4 (en) | DEVICES AND METHODS FOR THE TREATMENT OF VASCULAR ABNORMALITIES | |
| IL227193B (en) | Plant extracts for the treatment and prevention of inflammation | |
| IL227762A0 (en) | Devices and methods for the treatment of blood vessels in body cavities | |
| EP2486061A4 (en) | COMPOSITIONS AND METHODS FOR THE TRANSPORT OF THERAPEUTICS | |
| HK1180320A1 (en) | Pyrimidine derivatives and their use in the treatment of respiratory diseases such as copd copd | |
| EP2740489A4 (en) | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT AND / OR PREVENTION OF PANCREATIC CARCINOMA | |
| HUE036387T2 (hu) | Pirrolopirimidin származékok vírusfertõzések kezelésében való felhasználásra | |
| HK1180322A1 (en) | Pyrimidine derivatives and their use in the treatment of respiratory diseases such as copd copd | |
| EP2670345A4 (en) | DEVICES AND METHODS FOR TREATING VASCULAR AND PERSONAL CONDUITS | |
| PL2701645T3 (pl) | Urządzenie do leczenia i/lub zapobiegania chorobom rogówki | |
| EP2696874A4 (en) | COMPOSITIONS AND METHODS USED TO TREAT NASAL CONDITIONS | |
| EP2753363A4 (en) | MG53 COMPOSITIONS AND METHOD FOR THE TREATMENT AND PREVENTION OF RESPIRATORY INFLUENZES | |
| EP2575824A4 (en) | METHODS FOR THE TREATMENT AND PREVENTION OF INFLAMMATORY DISEASES | |
| HK1216721A1 (zh) | 治療肝臟疾病或病狀的用途和方法 | |
| EP2515939A4 (en) | VIRUSES UNDER THE EFFECT OF LIGHT, SYSTEMS AND METHODS OF USE THEREOF | |
| IL222482A0 (en) | Methods and compositions for the treatment of fluid accumulation in and/or under the retina | |
| EP2709630A4 (en) | PAR1 INHIBITORS FOR USE IN THE TREATMENT OR PREVENTION OF PARAMYXOVIRIDAE INFECTIONS | |
| HK1250484A1 (zh) | 用於治療胰腺炎的吉卡賓和衍生物 | |
| HK1202260A1 (en) | Agent for preventing and or treating veisalgia | |
| HK1165724A1 (en) | Albumin and/or mannitol for the treatment of nasal polyposis | |
| PT2389936E (pt) | Aminaftona para utilização no tratamento e/ou prevenção de enxaqueca | |
| IL243237A0 (en) | Methods and preparations for the treatment of fluid accumulation in and/or under the retina |